-
[This is the second part of a two-part series on electronic media resources. Last month we discussed the California STD/HIV Prevention Training Center's Youth Social Marketing Toolkit.]
-
-
With drug manufacturers retreating in recent years from voluntary discounts to family planning and other public clinics, providers increasingly rely on federally mandated discounts.
-
-
Several descriptive phrases are now being coined when family planning providers discuss such highly effective reversible methods as intrauterine contraception (ParaGard Copper T 380A intrauterine device, Duramed Pharmaceuticals, and the Mirena levonorgestrel intrauterine system, Bayer HealthCare Pharmaceuticals) and the contraceptive implant (Implanon, Schering-Plough Corp.).
-
An analysis presented at the 2010 National STD Prevention Conference gives a chilling look at impact of HIV and syphilis among U.S. gay and bisexual men.
-
An approach designed to reduce HIV and sexually transmitted diseases (STDs) in adolescents previously used exclusively by academic researchers now has been shown to be successfully implemented by community-based organizations (CBOs).
-
Much of the hotly debated health care reform legislation won't actually be implemented for months or years, but an expanded drug rebate program is an important exception. States can collect additional rebates right away, which may help some with severe budget shortfalls.
-
Like many state Medicaid directors, Elena Nicolella says that her biggest fiscal challenge is responding to an ever-increasing need for services with an ever-decreasing amount of revenue.
-
Athos Alexandrou, director of Maryland's Medicaid pharmacy program, says the state will benefit fiscally from the health care reform legislation's drug rebate program, by getting a share of rebates for pharmaceuticals dispensed by managed care organizations (MCOs). On the other hand, money will be lost on the fee-for-service side.
